Melatonin has membrane receptor-independent hypnotic action on neurons: An hypothesis

Journal of Pineal Research

Volumn 50, Issue 3, 2011, Pages 233-240

  Jan, James E ^a   Reiter, Russel J ^b   Wong, Peter K H ^a   Bax, Martin C O ^c   Ribary, Urs ^d   Wasdell, Michael B ^a,e  

^a BC CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d SIMON FRASER UNIVERSITY   (Canada)

^e BC Children's Hospital ^*  (Canada)

Author keywords

Cerebral connectivity; Children; Melatonin; Melatonin membrane receptor; Neurophysiology; Sleep; Suprachiasmatic nuclei

Indexed keywords

MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; MELATONIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

BINDING AFFINITY; BRAIN; CIRCADIAN RHYTHM; DRUG RECEPTOR BINDING; ELECTROENCEPHALOGRAPHY; HORMONE ACTION; HUMAN; HYPNOSIS; NEUROPHYSIOLOGY; NONHUMAN; NONREM SLEEP; REVIEW; SLEEP; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS;

HUMANS; MELATONIN; NEURONS; RECEPTORS, MELATONIN; SLEEP; SUPRACHIASMATIC NUCLEUS;

EID: 79952555798     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00844.x     Document Type: Review

References (89)

1. JAN JE, REITER RJ, WASDELL MB et al. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009; 46:1-7.
2. HOBSON JA. REM sleep and dreaming: towards a theory of protoconsciousness. Nat Rev Neurosci 2009; 10:803-813.
3. MENICUCCI D, PIARULLI A, DEBARNOT U et al. Functional structure of spontaneous sleep slow oscillation activity in humans. PLoS ONE 2009; 4:e7601.
4. ARENDT J. Melatonin and human rhythms. Chronobiol Int 2006; 23:21-37. (Pubitemid 43739016)
5. TERZIEVA DD, MATEVA ND, VLADIMIROVA-KITOVA LG. Melatonin reference limits at 3:00 AM and 8:00 AM in healthy adults. Clin Lab 2009; 55:359-361.
6. WASDELL MB, JAN JE, BOMBEN MM et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008; 44:57-64. (Pubitemid 350231110)
7. BORBELY AA. A two process model of sleep regulation. Hum Neurobiol 1982; 1:195-204. (Pubitemid 13213853)
8. MCCARLEY RW. Neurobiology of REM and NREM sleep. Sleep Med 2007; 8:302-330.
9. CIRELLI C. The genetic and molecular regulation of sleep: from fruit flies to humans. Nat Rev Neurosci 2009; 10:549-560.
10. JONES EG. Synchrony in the interconnected circuitry of the thalamus and cerebral cortex. Ann N Y Acad Sci 2009; 1157:10-23.
11. VYAZOVSKIY VV, OLCESE U, LAZIMY YM et al. Cortical firing and sleep homeostasis. Neuron 2009; 63:865-878.
12. MASSIMINI M, TONONI G, HUBER R. Slow waves, synaptic plasticity and information processing: insights from transcranial magnetic stimulation and high-density EEG experiments. Eur J Neurosci 2009; 29:1761-1770.
13. LLINAS R, RIBARY U, CONTRERAS D et al. The neuronal basis for consciousness. Philos Trans R Soc Lond B Biol Sci 1998; 353:1841-1849. (Pubitemid 28537291)
14. LERNER AB, CASE JD. Melatonin. Fed Proc 1960; 19:590-592.
15. REITER RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79:C153-C158.
16. REITER RJ, PAREDES SD, MANCHESTER LC et al. Reducing oxidative/ nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44:175-200.
17. TRICOIRE H, MOLLER M, CHEMINEAU P et al. Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl 2003; 61:311-321.
18. LESTON J, HARTHE C, BRUN J et al. Melatonin is released in the third ventricle in humans. A study in movement disorders. Neurosci Lett 2010; 469:294-297.
19. CRUMEYROLLE-ARIAS M, MEDVEDEV A, CARDONA A et al. Endogenous oxidized indoles share inhibitory potency against [3H]isatin binding in rat brain. J Neural Transm Suppl 2007; 72:29-34.
20. JIMENEZ-JORGE S, GUERRERO JM, JIMENEZ-CALIANI AJ et al. Evidence for melatonin synthesis in the rat brain during development. J Pineal Res 2007; 42:240-246. (Pubitemid 46365060)
21. SEIFMAN MA, ADAMIDES AA, NGUYEN PN et al. Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray. J Cereb Blood Flow Metab 2008; 28:684-696. (Pubitemid 351432798)
22. BRENNAN R, JAN JE, LYONS CJ. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology. Eye 2006; 21:901-908. (Pubitemid 47062070)
23. SKINNER DC, MALPAUX B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140:4399-4405. (Pubitemid 30666101)
24. REITER RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12:151-180.
25. DUBOCOVICH ML, DELAGRANGE P, KRAUSE DN et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G proteincoupled melatonin receptors. Pharmacol Rev 2010; 62:343-380.
26. HUGUENARD JR, MCCORMICK DA. Thalamic synchrony and dynamic regulation of global forebrain oscillations. Trends Neurosci 2007; 30:350-356. (Pubitemid 46991122)
27. STERIADE M, MCCORMICK DA, SEJNOWSKI TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science 1993; 262:679-685. (Pubitemid 23350685)
28. DE GENNARO L, FERRARA M. Sleep spindles: an overview. Sleep Med Rev 2003; 7:423-440. (Pubitemid 37221986)
29. KRUEGER JM, RECTOR DM, ROY S et al. Sleep as a fundamental property of neuronal assemblies. Nat Rev Neurosci 2008; 9:910-919.
30. COMPTE A, REIG R, DESCALZO VF et al. Spontaneous high-frequency (10-80 Hz) oscillations during up states in the cerebral cortex in vitro. J Neurosci 2008; 28:13828-13844.
31. KRISTIANSEN K, COURTOIS G. Rhythmic electrical activity from isolated cerebral cortex. Electroencephalogr Clin Neurophysiol 1949; 1:265-272.
32. MIGNOT E, HUGUENARD JR. Resting our cortices by going DOWN to sleep. Neuron 2009; 63:719-721.
33. VANHAUDENHUYSE A, NOIRHOMME Q, TSHIBANDA LJ et al. Default network connectivity reflects the level of consciousness in non-communicative brain-damaged patients. Brain 2010; 133:161-171.
34. ESSER SK, HILL S, TONONI G. Breakdown of effective connectivity during slow wave sleep: investigating the mechanism underlying a cortical gate using large-scale modeling. J Neurophysiol 2009; 102:2096-2111.
35. KUMAR S, RAO SL, CHANDRAMOULI BA et al. Reduction of functional brain connectivity in mild traumatic brain injury during working memory. J Neurotrauma 2009; 26:665-675.
36. THAI NJ, LONGE O, RIPPON G. Disconnected brains: what is the role of fMRI in connectivity research? Int J Psychophysiol 2009; 73:27-32.
37. JAN JE, RIBARY U, WONG PK et al. Cerebral modulation of circadian sleep-wake rhythms. J Clin Neurophysiol 2011; (in press).
38. MUSCAT L, MORIN LP. Intergeniculate leaflet: contributions to photic and non-photic responsiveness of the hamster circadian system. Neuroscience 2006; 140:305-320.
39. DIJK DJ, ROTH C, LANDOLT HP et al. Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity. Neurosci Lett 1995; 201:13-16.
40. SHIDA CS, CASTRUCCI AM, LAMY-FREUND MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16:198-201.
41. PIERI C, MARRA M, MORONI F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55:L271-L276.
42. KORKMAZ A, TOPAL T, TAN DX et al. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord 2009; 10:261-270.
43. GARDINER J, OVERALL R, MARC J. The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signaling. Synapse 2010; [epub ahead of print].
44. LEON J, ACUNA-CASTROVIEJO D, ESCAMES G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38:1-9. (Pubitemid 40139304)
45. WANG X. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 2009; 15:345-357.
46. REITER RJ, PAREDES SD, KORKMAZ A et al. Melatonin combats molecular terrorism at the mitochondrial level. Interdiscip Toxicol 2008; 1:137-149.
47. ACUNA-CASTROVIEJO D, MARTIN M, MACIAS M et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30:65-74. (Pubitemid 32176208)
48. BENITEZ-KING G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006; 40:1-9.
49. REITER RJ, TAN DX, MANCHESTER LC et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52:11-28.
50. JARZYNKA MJ, PASSEY DK, JOHNSON DA et al. Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence. J Pineal Res 2009; 46:161-171.
51. HARDELAND R, TAN DX, REITER RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47:109-126.
52. OLCESE JM, CAO C, MORI T et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 2009; 47:82-96.
53. LUCHETTI F, CANONICO B, BETTI M et al. Melatonin signaling and cell protection function. FASEB J 2010; 24:3603-3624.
54. ESTEBAN S, GARAU C, APARICIO S et al. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J Pineal Res 2010; 48:170-177.
55. PARADIES G, PETROSILLO G, PARADIES V et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48:297-310.
56. SANCHEZ-BARCELO EJ, MEDIAVILLA MD, TAN DX et al. Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 2010; 17:2070-2095.
57. LOPEZ LC, ESCAMES G, ORTIZ F et al. Melatonin restores the mitochondrial production of ATP in septic mice. Neuro Endocrinol Lett 2006; 27:623-630. (Pubitemid 46050020)
58. RODRIGUEZ MI, CARRETERO M, ESCAMES G et al. Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence- accelerated mice. Free Radic Res 2007; 41:15-24. (Pubitemid 44896871)
59. IKEDA M, IKEDA-SAGARA M, OKADA T et al. Brain oxidation is an initial process in sleep induction. Neuroscience 2005; 130:1029-1040. (Pubitemid 40094633)
60. TAN DX, CHEN LD, MANCHESTER LC. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
61. VIJAYALAXMI, REITER RJ, MELTZ ML. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995; 346:23-31.
62. XU SC, HE MD, ZHONG M et al. Melatonin protects against Nickel-induced neurotoxicity in vitro by reducing oxidative stress and maintaining mitochondrial function. J Pineal Res 2010; 49:86-94.
63. JAN JE, TAI J, HAHN G et al. Melatonin replacement therapy in a child with a pineal tumor. J Child Neurol 2001; 16:139-140. (Pubitemid 32390180)
64. LEU-SEMENESCU S, ARNULF I, DECAIX C et al. Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep 2010; 33:307-314.
65. VAN SOMEREN EJ, RIEMERSMA-VAN DER LEK RF. Live to the rhythm, slave to the rhythm. Sleep Med Rev 2007; 11:465-484. (Pubitemid 350087712)
66. ZAWILSKA JB, SKENE DJ, ARENDT J. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61:383-410.
67. BRAAM W, VAN GEIJLSWIJK I, KEIJZER H et al. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J Intellect Disabil Res 2010; 54:547-555.
68. SKENE DJ, ARENDT J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Med 2007; 8:651-655. (Pubitemid 47181208)
69. JAN JE, O'DONNELL ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21:193-199. (Pubitemid 126733135)
70. MISTLBERGER RE. Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev 2005; 49:429-454. (Pubitemid 41546654)
71. LESPERANCE P, DUMONT M. Melatonin administration in a blind child with irregular sleep-wake pattern and hypothalamic lesion. Sleep Res 1997; 26:730.
72. COHEN RA, ALBERS HE. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology 1991; 41:726-729.
73. WITT-ENDERBY PA, RADIO NM, DOCTOR JS et al. Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy. J Pineal Res 2006; 41:297-305. (Pubitemid 44498215)
74. PANDI-PERUMAL SR, TRAKHT I, SRINIVASAN V et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85:335-353.
75. FISHER SP, DAVIDSON K, KULLA A et al. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat. J Pineal Res 2008; 45:125-132.
76. DUBOCOVICH ML, MARKOWSKA M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27:101-110.
77. BONDI CD, MCKEON RM, BENNETT JM et al. MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation. J Pineal Res 2008; 44:288-298. (Pubitemid 351392943)
78. THOMAS L, PURVIS CC, DREW JE et al. Melatonin receptors in human fetal brain: 2-[(125)I]iodomelatonin binding and MT1 gene expression. J Pineal Res 2002; 33:218-224.
79. BRUNNER P, SOZER-TOPCULAR N, JOCKERS R et al. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Eur J Histochem 2006; 50:311-316. (Pubitemid 351480093)
80. MAZZUCCHELLI C, PANNACCI M, NONNO R et al. The melatonin receptor in the human brain: cloning experiments and distribution studies. Brain Res Mol Brain Res 1996; 39:117-126. (Pubitemid 26179152)
81. WITT-ENDERBY PA, BENNETT J, JARZYNKA MJ et al. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003; 72:2183-2198. (Pubitemid 36292142)
82. WASSMER E, CARTER PF, QUINN E et al. Melatonin is useful for recording sleep EEGs: a prospective audit of outcome. Dev Med Child Neurol 2001; 43:735-738. (Pubitemid 33054164)
83. ASHRAFI MR, MOHAMMADI M, TAFARROJI J et al. Melatonin versus chloral hydrate for recording sleep EEG. Eur J Paediatr Neurol 2010; 14:235-238.
84. WEIL ZM, HOTCHKISS AK, GATIEN ML et al. Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain Res Bull 2006; 68:425-429. (Pubitemid 43177577)
85. MUHLBAUER E, GROSS E, LABUCAY K et al. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606:61-71.
86. DUBOCOVICH ML. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246:902-910.
87. BUTTERWECK V, BRATTSTROEM A, GRUNDMANN O et al. Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole in mice. J Pharm Pharmacol 2007; 59:549-552. (Pubitemid 47051128)
88. YANG X. A wheel of time: the circadian clock, nuclear receptors, and physiology. Genes Dev 2010; 24:741-747.
89. YANG X, LAMIA KA, EVANS RM. Nuclear receptors, metabolism, and the circadian clock. Cold Spring Harb Symp Quant Biol 2007; 72:387-394.